Comparative tumor imaging and PDT efficacy of HPPH conjugated in the mono-and di-forms to various polymethine cyanine dyes: Part-2

Theranostics

Volumn 3, Issue 9, 2013, Pages 703-718

  James, Nadine S ^a   Ohulchanskyy, Tymish Y ^b   Chen, Yihui ^a   Joshi, Penny ^a   Zheng, Xiang ^a   Goswami, Lalit N ^a   Pandey, Ravindra K ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Fluorophores; Forster resonance energy transfer; Imaging; Photodynamic therapy; Reactive oxygen species

Indexed keywords

2 (1' HEXYLOXYETHYL) 2 DEVINYLPYROPHEOPHORBIDE A 1,2 ETHYLENEDIAMINE; 2 (1' HEXYLOXYETHYL) 2 DEVINYLPYROPHEOPHORBIDE A 2 DIETHYLENETRIAMINE; 2 (1' HEXYLOXYETHYL) 2 DEVINYLPYROPHEOPHORBIDE A 2 DIETHYLENETRIAMINE 8; 2 (1' HEXYLOXYETHYL) 2 DEVINYLPYROPHEOPHORBIDE A CYANINE DYE; 2 (1' HEXYLOXYETHYL) 2 DEVINYLPYROPHEOPHORBIDE A N BOC 1, 2 ETHYLENEDIAMINE; 2 (1' HEXYLOXYETHYL) 2 DEVINYLPYROPHEOPHORBIDE A N BOC ETHYLENEDIAMINE; 2 [1' HEXYLOXYETHYL] 2 DEVINYLPYROPHEOPHORBIDE A; CYANINE DYE; CYPATE; DI 2 (1' HEXYLOXYETHYL) 2 DEVINYLPYROPHEOPHORBIDE A CYPATE CONJUGATE; MONO 2 (1' HEXYLOXYETHYL) 2 DEVINYLPYROPHEOPHORBIDE A CYPATE CONJUGATE; PHOTOSENSITIZING AGENT; POLYMETHINE CYANINE DYE; SINGLET OXYGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL VIABILITY; COLON CARCINOMA; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; DRUG EFFICACY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG UPTAKE; FLUORESCENCE IMAGING; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LONG TERM CARE; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; STRUCTURE ANALYSIS; TUMOR DIAGNOSIS;

IMAGING. FORSTER RESONANCE ENERGY TRANSFER.; PHOTODYNAMIC THERAPY, FLUOROPHORES, REACTIVE OXYGEN SPECIES;

ANIMALS; CHLOROPHYLL; DISEASE MODELS, ANIMAL; FLUORESCENT DYES; HUMANS; INDOLES; MICE, NUDE; NEOPLASMS; OPTICAL IMAGING; PATHOLOGY, CLINICAL; PHOTOCHEMOTHERAPY; STAINING AND LABELING;

EID: 84883178771     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.5923     Document Type: Article

References (17)

1. Henderson BW, Dougherty TJ. How does photodynamic therapy work? Photochemistry and Photobiology. 1992; 55: 145-57.
2. Konan YN, Gurny R, Allemann E. State of the art in the delivery of photosensitizers for photodynamic therapy. J Photochem Photobiol, B. 2002; 66: 89-106.
3. Prasad PN. Introduction to Biophotonics. Hoboken, USA: John Wiley & Sons, Inc; 2003.
4. Kim S, Ohulchanskyy TY, Pudavar HE, Pandey RK, Prasad PN. Organically Modified Silica Nanoparticles Co-encapsulating Photosensitizing Drug and Aggregation-Enhanced Two-Photon Absorbing Fluorescent Dye Aggregates for Two-Photon Photodynamic Therapy. Journal of the American Chemical Society. 2007; 129: 2669-75.
5. Yan F, Kopelman R. The embedding of meta-tetra(hydroxyphenyl)-chlorin into silica nanoparticle platforms for photodynamic therapy and their singlet oxygen production and ph-dependent optical properties. Photochemistry and Photobiology. 2003; 78: 587-91.
6. Chen Y, Gryshuk A, Achilefu S, Ohulchansky T, Potter W, Zhong T, et al. A Novel Approach to a Bifunctional Photosensitizer for Tumor Imaging and Phototherapy. Bioconjugate Chemistry. 2005; 16: 1264-74.
7. Chen Y, Ohkubo K, Zhang M, Wenbo E, Liu W, Pandey Suresh K, et al. Photophysical, electrochemical characteristics and cross-linking of STAT-3 protein by an efficient bifunctional agent for fluorescence image-guided photodynamic therapy. Photochem Photobiol Sci. 2007; 6: 1257-67.
8. Srivatsan A, Ethirajan M, Pandey SK, Dubey S, Zheng X, Liu T-H, et al. Conjugation of cRGD Peptide to Chlorophyll a Based Photosensitizer (HPPH) Alters Its Pharmacokinetics with Enhanced Tumor-Imaging and Photosensitizing (PDT) Efficacy. Mol Pharmaceutics. 2011; 8: 1186-97. doi:10.1021/mp200018y.
9. Lovell JF, Chen J, Jarvi MT, Cao W-G, Allen AD, Liu Y, et al. FRET Quenching of Photosensitizer Singlet Oxygen Generation. Journal of Physical Chemistry B. 2009; 113: 3203-11.
10. Pandey RK, Bellnier DA, Smith KM, Dougherty TJ. Chlorin and porphyrin derivatives as potential photosensitizers in photodynamic therapy. Photochemistry and Photobiology. 1991; 53: 65-72.
11. Ye Y, Bloch S, Kao J, Achilefu S. Multivalent Carbocyanine Molecular Probes: Synthesis and Applications. Bioconjugate Chemistry. 2005; 16: 51-61.
12. James NS, Chen Y, Joshi P, Ohulchanskyy TY, Ethirajan M, Henary M, Strekowski L, Pandey RK. Evaluation of Polymethine Dyes as Potential Probes for Near Infrared Fluorescence Imaging of Tumors: Part -1. Theranostics 2013; 3(9):692-702.
13. Snyder JW, Greco WR, Bellnier DA, Vaughan L, Henderson BW. Photodynamic Therapy: A Means to Enhanced Drug Delivery to Tumors. Cancer Research. 2003; 63: 8126-31.
14. Henderson BW, Busch TM, Snyder JW. Fluence rate as a modulator of PDT mechanisms. Lasers in surgery and medicine. 2006; 38: 489-93.
15. Kuimova MK, Balaz M, Anderson HL, Ogilby PR. Intramolecular rotation in a porphyrin dimer controls singlet oxygen production. Journal of the American Chemical Society. 2009; 131: 7948-9. doi:10.1021/ja901237s.
16. Juzeniene A, Peng Q, Moan J. Milestones in the development of photodynamic therapy and fluorescence diagnosis. Photochemical & Photobiological Sciences. 2007; 6: 1234-45.
17. Minnes R, Weitman H, You Y, Detty Michael R, Ehrenberg B. Dithiaporphyrin derivatives as photosensitizers in membranes and cells. The journal of physical chemistry B. 2008; 112: 3268-76